Kristi Tough DeSapri, MD, founding physician at Bone and Body Womens Health, in Winnetka, Illinois, has noticed a marked uptick in her peri/menopausal patients asking about weight-loss drugsspecifically, glucagon-like peptide 1 (GLP-1) receptor antagonists, like Wegovy and Ozempic (a diabetes medicine linked with weight loss), among others
Approved alternatives Rybelsus, Wegovy, and Liraglutide are among the regulated drugs that include semaglutide or comparable substances
They may recommend other treatment options suitable for you
There is no substitute for personalised medical assessment when it comes to hormonal health and metabolic management
Contraindications Based on current understanding, the following represent potential contraindications: Active cancer or history of certain cancers